SALINE-FILLED BREAST IMPLANT AVAILABILITY SHOULD BE LIMITED
This article was originally published in The Gray Sheet
Executive SummarySALINE-FILLED BREAST IMPLANT AVAILABILITY SHOULD BE LIMITED to controlled trials, Public Citizen's Health Research Group says in an Aug. 4 petition to FDA. "Pending a final decision by the FDA regarding whether they are sufficiently safe and effective," HRG argues, "any further use of the devices should be limited" to a three-stage clinical protocol similar to that currently in place for silicone gel-filled breast implants.
You may also be interested in...
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.
At the OurCrowd Global Investor Summit, in Jerusalem, Israel, on 13 February, Medtech Insight met with start-up Sweetch, which has developed a personalized digital health coach for wellness and disease management.
Medtech Insight attended the OurCrowd Global Investor Summit in Jerusalem on February 13. At the meeting, Ofer Barnea, CEO of neurosurgery start-up SynCath Neuroscience, explained his company’s device to treat cerebral edema,